Private Equity
1 min read · 21 September 2018
Bonfire Ventures has set out to raise a $20 million venture-capital fund, according to a filing with the SEC.
1 min read · 21 September 2018
Florida and India-based CareStack, a technology platform for the dental industry, has raised $16 million in funding. Accel, F-Prime Capital Partners and Eight Roads Ventures led the round.
1 min read · 21 September 2018
Energize Ventures has raised over $101 million for its new fund, according to an SEC filing. No target was listed on the document.
1 min read · 21 September 2018
Santa Clara, California-based SI-BONE Inc, a medical device company, has filed for an IPO. The number of shares that will be sold as well as its pricing terms have yet to be set. SI-BONE plans on trading the stock on the NASDAQ under the ticker symbol "SIBN." Morgan Stanley and BofA Merrill Lynch are the lead underwriters. SI-BONE’s pre-IPO backers included Redline Capital Management, Orbimed, Novo A/S, Skyline Ventures and Montreux Equity Partners.
2 min read · 21 September 2018
Houston, Texas-based Tvardi Therapeutics, a biopharmaceutical company focused on developing STAT3 inhibitors, has closed $9 million in Series A financing. The investors were not named.
1 min read · 21 September 2018
Seattle-based Silverback Therapeutics Inc, a biotech company developing a pipeline of "systemically delivered, locally active" therapies, has extended its Series A financing round, bringing in the total tally to $47.5 million. OrbiMed led the round with participation from return backers Celgene Corporation and Alexandria Venture Investments.
1 min read · 21 September 2018
The Ziegler Link•Age Fund II L.P. has made investments in three healthcare-focused firms: Chronic Care Management, a technology and services care management provider; Socially Determined, a healthcare data company; and AllyAlign Health Inc, a care management services organization focused on helping long-term care providers,. No financial terms were disclosed.
7 min read · 20 September 2018
Egypt-based Vezeeta, a digital healthcare platform, has raised $12 million in Series C funding. STV led the round with participation from BECO Capital, Vostok New Ventures, Silicon Badia and Crescent Enterprises' CE Ventures.
2 min read · 20 September 2018
Malvern, Pennsylvania-based Galera Therapeutics Inc, a clinical-stage biotechnology company, has secured $150 million in Series C financing. Clarus led the round with participation from Adage Capital Management, HBM Healthcare Investments, Nan Fung Life Sciences, RA Capital, Rock Springs Capital, Tekla Capital Management LLC, Correlation Ventures, Galera Angels, New Enterprise Associates, Novartis Venture Fund, Novo Ventures and Sofinnova Ventures. In conjunction with the funding, Dr. Emmett T. Cunningham Jr, a managing director at Clarus, will join Galera’s board of directors.
1 min read · 20 September 2018